Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1991;84(Suppl 18):10–17.

Pathogenesis and management of lung disease in cystic fibrosis.

M S Zach 1
PMCID: PMC1293030  PMID: 2033570

Full text

PDF
10

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. App E. M., King M., Helfesrieder R., Köhler D., Matthys H. Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy. Am Rev Respir Dis. 1990 Mar;141(3):605–612. doi: 10.1164/ajrccm/141.3.605. [DOI] [PubMed] [Google Scholar]
  2. Auerbach H. S., Williams M., Kirkpatrick J. A., Colten H. R. Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis. Lancet. 1985 Sep 28;2(8457):686–688. doi: 10.1016/s0140-6736(85)92929-0. [DOI] [PubMed] [Google Scholar]
  3. Baltimore R. S., Mitchell M. Immunologic investigations of mucoid strains of Pseudomonas aeruginosa: comparison of susceptibility to opsonic antibody in mucoid and nonmucoid strains. J Infect Dis. 1980 Feb;141(2):238–247. doi: 10.1093/infdis/141.2.238. [DOI] [PubMed] [Google Scholar]
  4. Bedrossian C. W., Greenberg S. D., Singer D. B., Hansen J. J., Rosenberg H. S. The lung in cystic fibrosis. A quantitative study including prevalence of pathologic findings among different age groups. Hum Pathol. 1976 Mar;7(2):195–204. doi: 10.1016/s0046-8177(76)80023-8. [DOI] [PubMed] [Google Scholar]
  5. Bruce M. C., Poncz L., Klinger J. D., Stern R. C., Tomashefski J. F., Jr, Dearborn D. G. Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis. Am Rev Respir Dis. 1985 Sep;132(3):529–535. doi: 10.1164/arrd.1985.132.3.529. [DOI] [PubMed] [Google Scholar]
  6. Chrispin A. R., Norman A. P. The systematic evaluation of the chest radiograph in cystic fibrosis. Pediatr Radiol. 1974;2(2):101–105. doi: 10.1007/BF01314939. [DOI] [PubMed] [Google Scholar]
  7. Eber E., Oberwaldner B., Zach M. S. Airway obstruction and airway wall instability in cystic fibrosis: the isolated and combined effect of theophylline and sympathomimetics. Pediatr Pulmonol. 1988;4(4):205–212. doi: 10.1002/ppul.1950040404. [DOI] [PubMed] [Google Scholar]
  8. Esterly J. R., Oppenheimer E. H. Observations in cystic fibrosis of the pancreas. 3. Pulmonary lesions. Johns Hopkins Med J. 1968 Feb;122(2):94–101. [PubMed] [Google Scholar]
  9. Fick R. B., Jr Pathogenesis of the pseudomonas lung lesion in cystic fibrosis. Chest. 1989 Jul;96(1):158–164. doi: 10.1378/chest.96.1.158. [DOI] [PubMed] [Google Scholar]
  10. Gold R., Carpenter S., Heurter H., Corey M., Levison H. Randomized trial of ceftazidime versus placebo in the management of acute respiratory exacerbations in patients with cystic fibrosis. J Pediatr. 1987 Dec;111(6 Pt 1):907–913. doi: 10.1016/s0022-3476(87)80217-2. [DOI] [PubMed] [Google Scholar]
  11. Goldstein W., Döring G. Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis. Am Rev Respir Dis. 1986 Jul;134(1):49–56. doi: 10.1164/arrd.1986.134.1.49. [DOI] [PubMed] [Google Scholar]
  12. Hingley S. T., Hastie A. T., Kueppers F., Higgins M. L., Weinbaum G., Shryock T. Effect of ciliostatic factors from Pseudomonas aeruginosa on rabbit respiratory cilia. Infect Immun. 1986 Jan;51(1):254–262. doi: 10.1128/iai.51.1.254-262.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hordvik N. L., König P., Morris D., Kreutz C., Barbero G. J. A longitudinal study of bronchodilator responsiveness in cystic fibrosis. Am Rev Respir Dis. 1985 Jun;131(6):889–893. doi: 10.1164/arrd.1985.131.6.889. [DOI] [PubMed] [Google Scholar]
  14. Hornick D. B. Pulmonary host defense: defects that lead to chronic inflammation of the airway. Clin Chest Med. 1988 Dec;9(4):669–678. [PubMed] [Google Scholar]
  15. Høiby N., Döring G., Schiøtz P. O. The role of immune complexes in the pathogenesis of bacterial infections. Annu Rev Microbiol. 1986;40:29–53. doi: 10.1146/annurev.mi.40.100186.000333. [DOI] [PubMed] [Google Scholar]
  16. Jones J. G., Fraser R. B., Nadel J. A. Effect of changing airway mechanics on maximum expiratory flow. J Appl Physiol. 1975 Jun;38(6):1012–1021. doi: 10.1152/jappl.1975.38.6.1012. [DOI] [PubMed] [Google Scholar]
  17. Knowles M., Gatzy J., Boucher R. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. N Engl J Med. 1981 Dec 17;305(25):1489–1495. doi: 10.1056/NEJM198112173052502. [DOI] [PubMed] [Google Scholar]
  18. Kuusela P. Fibronectin binds to Staphylococcus aureus. Nature. 1978 Dec 14;276(5689):718–720. doi: 10.1038/276718a0. [DOI] [PubMed] [Google Scholar]
  19. Lam J., Chan R., Lam K., Costerton J. W. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect Immun. 1980 May;28(2):546–556. doi: 10.1128/iai.28.2.546-556.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Landau L. I., Phelan P. D. The spectrum of cystic fibrosis. A study of pulmonary mechanics in 46 patients. Am Rev Respir Dis. 1973 Sep;108(3):593–602. doi: 10.1164/arrd.1973.108.3.593. [DOI] [PubMed] [Google Scholar]
  21. Langford D. T., Hiller J. Prospective, controlled study of a polyvalent pseudomonas vaccine in cystic fibrosis--three year results. Arch Dis Child. 1984 Dec;59(12):1131–1134. doi: 10.1136/adc.59.12.1131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Levy L. D., Durie P. R., Pencharz P. B., Corey M. L. Effects of long-term nutritional rehabilitation on body composition and clinical status in malnourished children and adolescents with cystic fibrosis. J Pediatr. 1985 Aug;107(2):225–230. doi: 10.1016/s0022-3476(85)80130-x. [DOI] [PubMed] [Google Scholar]
  23. Mansell A. L., Andersen J. C., Muttart C. R., Ores C. N., Loeff D. S., Levy J. S., Heird W. C. Short-term pulmonary effects of total parenteral nutrition in children with cystic fibrosis. J Pediatr. 1984 May;104(5):700–705. doi: 10.1016/s0022-3476(84)80947-6. [DOI] [PubMed] [Google Scholar]
  24. Mearns M. B., Hunt G. H., Rushworth R. Bacterial flora of respiratory tract in patients with cystic fibrosis, 1950-71. Arch Dis Child. 1972 Dec;47(256):902–907. doi: 10.1136/adc.47.256.902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Mellins R. B., Levin O. R., Ingram R. H., Jr, Fishman A. P. Obstructive disease of the airways in cystic fibrosis. Pediatrics. 1968 Mar;41(3):560–573. [PubMed] [Google Scholar]
  26. Michel B. C. Antibacterial therapy in cystic fibrosis. A review of the literature published between 1980 and February 1987. Chest. 1988 Aug;94(2 Suppl):129S–140S. doi: 10.1378/chest.94.2.129s. [DOI] [PubMed] [Google Scholar]
  27. Nicolai T., Hüttner K., Zach M. Der Einfluss von Luftwegsinstabilität und Alveolargaskompression auf bronchodilatatorinduzierte Anderungen von Fluss-Volumenkurve und Luftwegsresistance. Prax Klin Pneumol. 1988 Feb;42(2):45–49. [PubMed] [Google Scholar]
  28. Oberwaldner B., Evans J. C., Zach M. S. Forced expirations against a variable resistance: a new chest physiotherapy method in cystic fibrosis. Pediatr Pulmonol. 1986 Nov-Dec;2(6):358–367. doi: 10.1002/ppul.1950020608. [DOI] [PubMed] [Google Scholar]
  29. Olsen C. R., Stevens A. E., McIlroy M. B. Rigidity of tracheae and bronchi during muscular constriction. J Appl Physiol. 1967 Jul;23(1):27–34. doi: 10.1152/jappl.1967.23.1.27. [DOI] [PubMed] [Google Scholar]
  30. Ormerod L. P., Thomson R. A., Anderson C. M., Stableforth D. E. Reversible airway obstruction in cystic fibrosis. Thorax. 1980 Oct;35(10):768–772. doi: 10.1136/thx.35.10.768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Prince H. E., Folds J. D., Spitznagel J. K. Proteolysis of human IgG by human polymorphonuclear leucocyte elastase produces an Fc fragment with in vitro biological activity. Clin Exp Immunol. 1979 Jul;37(1):162–168. [PMC free article] [PubMed] [Google Scholar]
  32. Ramphal R., Pier G. B. Role of Pseudomonas aeruginosa mucoid exopolysaccharide in adherence to tracheal cells. Infect Immun. 1985 Jan;47(1):1–4. doi: 10.1128/iai.47.1.1-4.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Ramphal R., Pyle M. Adherence of mucoid and nonmucoid Pseudomonas aeruginosa to acid-injured tracheal epithelium. Infect Immun. 1983 Jul;41(1):345–351. doi: 10.1128/iai.41.1.345-351.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Ramphal R., Sadoff J. C., Pyle M., Silipigni J. D. Role of pili in the adherence of Pseudomonas aeruginosa to injured tracheal epithelium. Infect Immun. 1984 Apr;44(1):38–40. doi: 10.1128/iai.44.1.38-40.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Ramphal R., Small P. M., Shands J. W., Jr, Fischlschweiger W., Small P. A., Jr Adherence of Pseudomonas aeruginosa to tracheal cells injured by influenza infection or by endotracheal intubation. Infect Immun. 1980 Feb;27(2):614–619. doi: 10.1128/iai.27.2.614-619.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Regelmann W. E., Elliott G. R., Warwick W. J., Clawson C. C. Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone. Am Rev Respir Dis. 1990 Apr;141(4 Pt 1):914–921. doi: 10.1164/ajrccm/141.4_Pt_1.914. [DOI] [PubMed] [Google Scholar]
  37. Reisman J. J., Rivington-Law B., Corey M., Marcotte J., Wannamaker E., Harcourt D., Levison H. Role of conventional physiotherapy in cystic fibrosis. J Pediatr. 1988 Oct;113(4):632–636. doi: 10.1016/s0022-3476(88)80370-6. [DOI] [PubMed] [Google Scholar]
  38. Russell N. J., Gacesa P. Chemistry and biology of the alginate of mucoid strains of Pseudomonas aeruginosa in cystic fibrosis. Mol Aspects Med. 1988;10(1):1–91. doi: 10.1016/0098-2997(88)90002-7. [DOI] [PubMed] [Google Scholar]
  39. Sanchis J., Dolovich M., Rossman C., Wilson W., Newhouse M. Pulmonary mucociliary clearance in cystic fibrosis. N Engl J Med. 1973 Mar 29;288(13):651–654. doi: 10.1056/NEJM197303292881304. [DOI] [PubMed] [Google Scholar]
  40. Schiøtz P. O., Clemmensen I., Høiby N. Immunoglobulins and albumin in sputum from patients with cystic fibrosis. A study of protein stability and presence of proteases. Acta Pathol Microbiol Scand C. 1980 Oct;88(5):275–280. doi: 10.1111/j.1699-0463.1980.tb00106.x. [DOI] [PubMed] [Google Scholar]
  41. Scott J., Higenbottam T., Hutter J., Hodson M., Stewart S., Penketh A., Wallwork J. Heart-lung transplantation for cystic fibrosis. Lancet. 1988 Jul 23;2(8604):192–194. doi: 10.1016/s0140-6736(88)92290-8. [DOI] [PubMed] [Google Scholar]
  42. Shepherd R., Cooksley W. G., Cooke W. D. Improved growth and clinical, nutritional, and respiratory changes in response to nutritional therapy in cystic fibrosis. J Pediatr. 1980 Sep;97(3):351–357. doi: 10.1016/s0022-3476(80)80180-6. [DOI] [PubMed] [Google Scholar]
  43. Sobonya R. E., Taussig L. M. Quantitative aspects of lung pathology in cystic fibrosis. Am Rev Respir Dis. 1986 Aug;134(2):290–295. doi: 10.1164/arrd.1986.134.2.290. [DOI] [PubMed] [Google Scholar]
  44. Solomon A., Gramse M., Havemann K. Proteolytic cleavage of human IgG molecules by neutral proteases of polymorphonuclear leukocytes. Eur J Immunol. 1978 Nov;8(11):782–785. doi: 10.1002/eji.1830081106. [DOI] [PubMed] [Google Scholar]
  45. Suter S. Imbalance between polymorphonuclear leukocyte proteases and antiproteases in chronic pyogenic infections and its relation to the proteolysis of complement component C3. Complement. 1986;3(1):1–24. doi: 10.1159/000467874. [DOI] [PubMed] [Google Scholar]
  46. Suter S., Schaad U. B., Roux L., Nydegger U. E., Waldvogel F. A. Granulocyte neutral proteases and Pseudomonas elastase as possible causes of airway damage in patients with cystic fibrosis. J Infect Dis. 1984 Apr;149(4):523–531. doi: 10.1093/infdis/149.4.523. [DOI] [PubMed] [Google Scholar]
  47. Suter S., Schaad U. B., Tegner H., Ohlsson K., Desgrandchamps D., Waldvogel F. A. Levels of free granulocyte elastase in bronchial secretions from patients with cystic fibrosis: effect of antimicrobial treatment against Pseudomonas aeruginosa. J Infect Dis. 1986 May;153(5):902–909. doi: 10.1093/infdis/153.5.902. [DOI] [PubMed] [Google Scholar]
  48. Tomashefski J. F., Jr, Bruce M., Goldberg H. I., Dearborn D. G. Regional distribution of macroscopic lung disease in cystic fibrosis. Am Rev Respir Dis. 1986 Apr;133(4):535–540. doi: 10.1164/arrd.1986.133.4.535. [DOI] [PubMed] [Google Scholar]
  49. Van Wye J. E., Collins M. S., Baylor M., Pennington J. E., Hsu Y. P., Sampanvejsopa V., Moss R. B. Pseudomonas hyperimmune globulin passive immunotherapy for pulmonary exacerbations in cystic fibrosis. Pediatr Pulmonol. 1990;9(1):7–18. doi: 10.1002/ppul.1950090104. [DOI] [PubMed] [Google Scholar]
  50. Wentworth P., Gough J., Wentworth J. E. Pulmonary changes and cor pulmonale in mucoviscidosis. Thorax. 1968 Nov;23(6):582–589. doi: 10.1136/thx.23.6.582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Woods D. E., Bass J. A., Johanson W. G., Jr, Straus D. C. Role of adherence in the pathogenesis of Pseudomonas aeruginosa lung infection in cystic fibrosis patients. Infect Immun. 1980 Dec;30(3):694–699. doi: 10.1128/iai.30.3.694-699.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Woods D. E., Straus D. C., Johanson W. G., Jr, Berry V. K., Bass J. A. Role of pili in adherence of Pseudomonas aeruginosa to mammalian buccal epithelial cells. Infect Immun. 1980 Sep;29(3):1146–1151. doi: 10.1128/iai.29.3.1146-1151.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Yeates D. B., Sturgess J. M., Kahn S. R., Levison H., Aspin N. Mucociliary transport in trachea of patients with cystic fibrosis. Arch Dis Child. 1976 Jan;51(1):28–33. doi: 10.1136/adc.51.1.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Zach M. S. Lung disease in cystic fibrosis--an updated concept. Pediatr Pulmonol. 1990;8(3):188–202. doi: 10.1002/ppul.1950080311. [DOI] [PubMed] [Google Scholar]
  55. Zach M. S., Oberwaldner B. Chest physiotherapy--the mechanical approach to antiinfective therapy in cystic fibrosis. Infection. 1987;15(5):381–384. doi: 10.1007/BF01647750. [DOI] [PubMed] [Google Scholar]
  56. Zach M. S., Oberwaldner B., Forche G., Polgar G. Bronchodilators increase airway instability in cystic fibrosis. Am Rev Respir Dis. 1985 Apr;131(4):537–543. doi: 10.1164/arrd.1985.131.4.537. [DOI] [PubMed] [Google Scholar]
  57. Zapletal A., Houstek J., Samanek M., Vavrova V., Srajer J. Lung function abnormalities in cystic fibrosis and changes during growth. Bull Eur Physiopathol Respir. 1979 Jul-Aug;15(4):575–592. [PubMed] [Google Scholar]
  58. Zapletal A., Motoyama E. K., Gibson L. E., Bouhuys A. Pulmonary mechanics in asthma and cystic fibrosis. Pediatrics. 1971 Jul;48(1):64–72. [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES